Work

Efficacy and safety of cosibelimab, an anti–PD-L1 antibody, in patients with metastatic cutaneous squamous cell carcinoma.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.9537

Authors: Philip R. Clingan, Daniel Brungs, Susan Arnold, Jermaine Coward, Samuel J. Fourie, Dean Laurence Harris, Andrii Kurochkin, Rahul Ladwa, Niel Malan, Andrew Michael Mant, Margie McGrath, Vinay Sharma, Hong Shue, Andrea Tazbirkova, James Oliviero, Jayesh Desai

Institutions: Icon (Australia), Christchurch Hospital, The University of Queensland, Princess Alexandra Hospital, Eastern Health, Greenslopes Private Hospital, Gallipoli Medical Research Foundation, University of the Witwatersrand, Peter MacCallum Cancer Centre

Language: English

Topic: Nonmelanoma Skin Cancer Studies

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4286294604

Cites:

Cited by: 3

Related to: 10